Syqe Medical Overview

  • Founded

  • 2011

Founded
  • Status

  • Private

  • Employees

  • 105

Employees
  • Latest Deal Type

  • PE Growth

  • Financing Rounds

  • 5

Syqe Medical General Information

Description

Developer of pocket-sized metered-dose cannabis inhaler designed to allow patients to reach the optimum balance between symptom relief and psycho-activities. The company's technologies offer precise delivery of a wide range of therapeutic molecules, active compounds and botanicals, including cannabis by inhalation through predictable, precise and consistent treatment at pharmaceutical standards using automation that ensures bioavailability with natural inspiration and remote clinical monitoring, enabling patients to have enables reduction of the intensity of chronic neuropathic pain with minimum psychoactive adverse effects

Contact Information

Website
www.syqe.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Jaffa
  • Tel Aviv 6816915
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syqe Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Syqe Medical‘s full profile, request access.

Request a free trial

Syqe Medical Patents

  • 179

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 17

    Granted

  • 8

    Pending

  • 000

    Expiring in next 12 mo

Syqe Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021342819-A1 Devices and methods for low latency oral authentication Pending 14-Sep-2021
US-20230120935-A1 Devices and methods for low latency oral authentication Pending 16-Sep-2020 000000000 0
CA-3195209-A1 Devices and methods for low latency oral authentication Pending 16-Sep-2020 0000000000
AU-2020279079-A1 Substance delivery planning system Pending 21-May-2019 000000000
CA-3140382-A1 Substance delivery planning system Pending 21-May-2019 G16H20/13
To view Syqe Medical’s complete patent history, request access »

Syqe Medical Executive Team (14)

Name Title Board Seat Contact Info
Perry Davidson Co-Founder & Group Chief Executive Officer
Hagit Kamin Chief Executive Officer
Ido Zur Chief Financial Officer
Benjamin Schwartz Co-Founder & Chief Technology Officer
Seth Kindler MD Chief Science Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Syqe Medical Board Members (2)

Name Representing Role Since
00000 000000 Syqe Medical Co-Founder & Board Member 000 0000
00000 0000 00 Syqe Medical Executive Medical Chairman 000 0000
To view Syqe Medical’s complete board members history, request access »

Syqe Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Syqe Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Syqe Medical‘s full profile, request access.

Request a free trial